YH 33619
Alternative Names: YH-33619Latest Information Update: 20 Jan 2022
Price :
$50 *
At a glance
- Originator Yuhan
- Developer Gilead Sciences; Yuhan
- Class Anti-inflammatories; Hepatoprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Non-alcoholic steatohepatitis